ArticlePDF Available

Giant Cell Tumour of Soft Tissue of the Finger: A Case Report

Authors:
  • University of Calabar Teaching Hospital, Nigeria, Calabar

Abstract and Figures

Giant cell tumour of soft tissue resembling osseous giant cell tumour is a distinct and uncommon entity. Presented is a 52-year-old man with a 3-year history of swelling located on the dorsum of the right middle finger diagnosed on histology as giant cell tumour of soft tissue. The need for high index of suspicion by physicians is emphasized, as giant cell tumour of soft tissue should be considered as differential diagnosis of finger lumps.
Content may be subject to copyright.
a SciTechnol journal
Case Report
Asuquo et al., J Clin Exp Oncol 2013, 2:3
http://dx.doi.org/10.4172/2324-9110.1000110 Journal of Clinical &
Experimental Oncology
All articles published in Journal of Clinical & Experimental Oncology are the property of SciTechnol, and is protected by
copyright laws. Copyright © 2013, SciTechnol, All Rights Reserved.
International Publisher of Science,
Technology and Medicine
Giant Cell Tumour of Soft
Tissue of the Finger: A Case
Report
ME Asuquo1*, VI Nwagbara1, C Agbor1, S Akpan1, G Ebughe2
and T Ugbem2
Abstract
Giant cell tumour of soft tissue resembling osseous giant cell
tumour is a distinct and uncommon entity. Presented is a 52-year-
old man with a 3-year history of swelling located on the dorsum of
the right middle nger diagnosed on histology as giant cell tumour
of soft tissue. The need for high index of suspicion by physicians
is emphasized, as giant cell tumour of soft tissue should be
considered as differential diagnosis of nger lumps.
Keywords
Giant cells; Soft tissue
*Corresponding author: ME Asuquo, Department of Surgery, University of
Calabar Teaching Hospital, Calabar, Nigeria, GPO Box 1891, Calabar, 540001,
Nigeria, E-mail: mauefas@yahoo.com
Received: February 27, 2013 Accepted: April 12, 2013 Published: April 19,
2013
Examination revealed a middle-aged male in relative good health,
afebrile, not pale. On the right hand, there was an irregular nodular
mass on the dorsal surface of the right middle nger measuring
5x3 cm, non-tender, rm, mobile and not attached to the skin and
underlying structures. ere was no regional lymphadenopathy
(Figure 1).
Haemogram and urinalysis were unremarkable. Plain X-ray
of the right hand showed a well-dened unmineralised so tissue
mass around the proximal interphalangeal joint of the middle nger,
with a normal adjoining cortex of the phalanx (Figure 2). A clinical
diagnosis of a broma of the right middle nger was made.
Marginal excision biopsy of the mass was done under a ring block.
It revealed an irregular, lobulated, encapsulated mass (Figure 3).
Histopathology report showed a tumour composed of proliferating
uniform oval mononuclear cells in a myxoid stroma. Scattered
around the background were numerous osteoclast-type giant cells
having many nuclei that resemble the nuclei of mononuclear cells.
No malignancy was seen, Figure 4a and 4b. A diagnosis of giant cell
tumour of so tissue (GCT-ST) of the right middle nger was made.
Follow-up in the SOPD has been satisfactory and patient
informed of the need for follow up.
Discussion
Giant cell tumour of the so tissue is a primary so tissue
neoplasm, it closely resembles GCT of bone cytomorphologically as
the giant cells resemble osteoclast, however both are distinct entities
[5,7], as depicted by our patient. is rare entity rst described by
Salm and Sissons in 1972 [3], was also described by Guccion and
Enzinger later in the same year [6].
e histiogenesis of this tumour is not certain, but it is postulated
that osteoclast-like cells are the result of fusion of circulating monocytes
recruited into the lesion [2,8]. Giant cell tumour of so tissue though
predominantly a benign condition, demonstrates unpredictable
capacity to occasionally recur or evolve into a malignant lesion [2].
Reported recurrence rate is 6.2%, though infrequent, metastasis to the
lungs and parotid glands have been described [4,5]. is underscores
the need to ensure a tumour free margin post excision and follow
up of patients, as the tumour biology of this lesion is not completely
known.
It aects mainly adults of both sexes [2], in keeping with our male
patient aged 52 years. Oliveria et al. reported an age range of 5-80
years (median 43 years), [5], while Tagera-Vaquerizo et al. reported
an age range of 5-84 years [8], both with no predilection for sex.
is lesion, predominantly found in the lower limb with the trunk
and upper limb ranking second and third respectively [5,8]. Kumar
and Carter reported that the hand is rarely involved [1]. However,
Chand et al. reported that the commonest site was the upper limb,
nger being the most common location [2]. Our patient’s lesion was
located on the dorsum of the right middle nger. In keeping with
reported nger lesions, Tejera-Vaquerizo reported a distal phalanx
Introduction
Giant cell tumour of so tissue (GCT-ST) is a rare entity and
has a histopathological semblance of osteoclast like multinucleated
giant cells seen in the osseous counterpart [1,2]. Salm and Sisson rst
coined the term primary GCT-ST in 1972 [3]. It presents as a painless,
rm, mobile, well-delineated mass not attached to muscle, tendon,
or bone [4]. Most of the lesions are seen in the lower limb, the most
common site being the thigh, followed by trunk and upper limb [5]. If
surgically treated by excision with tumour free margin, it is expected
to have a benign clinical course [1]. However, despite being a benign
lesion, it may recur aer excision, has the potential of malignant
transformation, and rarely metastasize [6]. We report a case of GCT-
ST of the dorsum of the middle nger in a 52-year-old man.
Case Summary
A 52-year old businessperson, who had recovered from three
cerebrovascular accidents aecting the le cerebral hemisphere, was
referred from the medical out patient department (MOPD) to the
surgical out patient department (SOPD) with a 3-year history of a
swelling on the right middle nger. e swelling began as a nodule 3
years ago, but gradually increased in size, becoming multilobulated.
ere was no associated history of trauma or arthritis, pain or
limitation of movement of the aected nger and no similar swellings
in other parts of the body. He is a known hypertensive on nifedipine
medication.
Citation: Asuquo ME , Nwagbara VI , Agbor C, Akpan S, Ebughe G, et al. (2013) Giant Cell Tumour of Soft Tissue of the Finger: A Case Report. J Clin Exp
Oncol 2:3.
Page 2 of 3
doi:http://dx.doi.org/10.4172/2324-9110.1000110
Volume 2 • Issue 3 • 1000110
lesion of the right ring nger with a cystic component [8], this was
not a feature in the reported lesion. Mardi and Sharma reported a
case on the dorsum of the right hand over the index nger [9]. Breast
is exceedingly rare site aected by GCT-ST; rst case reported was
fatal [10].
Chand et al. reported that none of the cases they reported was
clinically suspected as GCT-ST in keeping with our experience. ey
present frequently as skin tumour and may be supercial as the case
presented, Figure 1 or may be in deep body tissue [2]. Painless, rm,
mobile, well-demarcated mass, not attached to muscle, tendon, or
bone is the common mode of presentation [4].
ere are no reported gross features that distinguish between
benign and malignant variants. Diagnosis is histologic with
appearance of osteoclast-like giant cells and mononuclear cells
(Figures 4a and 4b). Giant cell tumour of so tissue is required to be
distinguished from giant cell rich tumours of the bone, and GCT of
tendon sheath. Plain radiograph is sensitive in the diagnosis of a bone
lesion or its exclusion as shown in the case presented with a normal
phalanx (Figure 2). e use of cross sectional imaging, magnetic
resonance imaging (MRI), is capable of distinguishing GCT of the
tendon from GCT-ST. However, the location of the lesion mainly on
the dorsolateral part of the anatomical position of the nger, Figure 1,
suggested that the diagnosis of GCT of the tendon sheath is unlikely,
and this conrmed at surgery. e immunohistochemical staining of
GCT-ST is similar to that of GCT of bone; strong positive staining for
CD 68 in multinucleated osteoclast like cells and in mononuclear cells
focal staining for CD6, Ham 56 and smooth muscle actin [9]. Other
so tissue neoplasms are dermatobroma, atypical broxanthomas,
brohistiocytic tumour, giant cell malignant brous histiocytoma.
e treatment of GCT-ST is surgical resection with tumour free
margin. Follow up of these patients is necessary because of possibility
of recurrence and malignant transformation of this tumour [2,8].
e prognosis of GCT-ST varies and the biological aggressive course
for its local recurrence cannot be predicted in view of the wide
clinicopathological spectrum exhibited by this tumour [2].
In conclusion, the need for high index of suspicion by physicians
to consider GCT-ST as dierential diagnosis of lumps of the nger
is emphasised. is lesion with usually a benign course has the
propensity to be malignant with grave consequences.
References
1. Kumar S, Carter LF (2011) Giant cell tumor of soft tissue of hand: simple but
rare diagnosis, which is often missed. Clinics and Practice 1: e54.
2. Chand K, Bhardwaj RK, Rappai TJ (2006) Study of 7 cases of giant cell tumor
of soft tissue. MJAFI 62: 138-140.
3. Salm R, Sissons HA (1972) Giant cell tumors of soft tissue. J Pathol 107: 29-
39.
4. Nguyen V, Garcia C, Haskell H (2010) Giant cell tumor of soft tissue on the
thigh of a 40-year-old woman. Dermatol Online J 16: 2.
5. Oliveira AM, DeiTos AP, Fletcher CD, Nascimento AG (2000) Primary giant
cell tumor of soft tissues: a study of 22 cases. Am J Surg Pathol 24: 248-256.
Figure 1: Clinical photograph giant cell tumour of soft tissue.
Figure 2: Plain X-ray right hand.
Figure 3: Macroscopic photograph of giant cell tumour of soft tissue.
Figure 4a: Giant cell tumour of soft tissue – H&E x 40.
Figure 4b: Giant cell tumour of soft tissue H&E x 100.
Citation: Asuquo ME , Nwagbara VI , Agbor C, Akpan S, Ebughe G, et al. (2013) Giant Cell Tumour of Soft Tissue of the Finger: A Case Report. J Clin Exp
Oncol 2:3.
Page 3 of 3
doi:http://dx.doi.org/10.4172/2324-9110.1000110
Volume 2 • Issue 3 • 1000110
6. Guccion JG, Enzinger FM (1972) Malignant giant cell tumor of soft perts. An
analysis of 32 cases. Cancer 29: 1518-1529.
7. O’Connell JX, Wehrli BM, Nielson GP, Rosenburg AE (2000) Giant cell
tumors of soft tissue: a clinicopathological study of 18 benign and malignant
tumors. Am J Surg Pathol 24: 386-395.
8. Tejera-Vaquerizo A, Ruiz-Molina I, Gonzalez-Serrano T, Solis-Garcia E
(2008) Primary giant cell tumor of soft tissue in the nger. Dermatol Online J
14: 7.
9. Mardi K, Sharma J (2007) Primary giant cell tumour of soft parts- Report of a
case with ne needle aspiration cytology and histology ndings. J Cytol 24:
58-59.
10. May SA, Deavers MT, Resetkova E, Johnson D, Albarracin CT (2007) Giant
cell tumor of soft tissue arising in breast. Ann Diagn Pathol 11: 345-349.
Submit your next manuscript and get advantages of SciTechnol
submissions
50 Journals
21 Day rapid review process
1000 Editorial team
2 Million readers
More than 5000
Publication immediately after acceptance
Quality and quick editorial, review processing
Submit your next manuscript at www.scitechnol.com/submission
Author Afliations Top
1Department of Surgery, University of Calabar Teaching Hospital, Calabar,
Nigeria
2Department of Pathology, University of Calabar Teaching Hospital, Calabar,
Nigeria
... La radiografía simple se utiliza para el diagnó stico o la exclusió n de la lesió n ó sea. El uso de imá genes en secció n transversal y la resonancia magné tica, son capaces de distinguir GCT del tendó n de GCT-ST 6 . ...
... La tasa de recurrencia reportada es de 6,2%, y aunque poco frecuentes, las metá stasis a los pulmones y glá ndulas paró tidas se han descrito 6 . Esto pone de relieve la necesidad de garantizar una escisió n con má rgenes libres de tumor y el seguimiento de los pacientes, ya que la biología de esta lesió n no es completamente conocida 6 . En pacientes con un seguimiento de 34 a 45 meses se observa una recurrencia local del 12%, y la exé resis incompleta es seguida de recurrencia local 2 . ...
Article
Giant cell tumour of soft tissue (GCT-ST) is an uncommon entity which histopathologically resembles bony GCT. We report a case of giant cell tumour in a 45-year-old male patient who presented to the dermatology department with a gradually enlarging painless, smooth swelling over second toe of left foot. Histopathology revealed it to be giant cell tumour of soft tissue.
Article
Full-text available
Giant cell tumor of soft tissue originally described in 1972 in two different series by Salm and Sissons is a rare entity, which is clinically and histopathologically indistinguishable from giant cell tumor of bone. Usually involve thigh, trunk, and lower extremities but rarely involve the hands. GCT-ST is a benign tumor, which can transform into malignant form and also has potential for recurrence and metastasis. We present an otherwise healthy, middle age female who originally presented with swellings on her left finger was diagnosed with giant cell tumor of soft tissue hand.
Article
Background: Primary giant cell tumour of soft tissues is a distinct but uncommon group of neoplasms morphologically identical to osseous giant cell tumor. Methods: 7 patients with painless growing soft tissue mass, having no attachment to underlying bone, were identified in a four years retrospective study from two zonal hospitals of armed forces. Histopathology of these lesions revealed admixture of multinucleated giant cell with mononuclear cells. All patients were treated by surgical resection and followed up for recurrence. Results : There were 5 male and 2 female patients in the age group of 18 to 56 years. All lesions were superficial, circumscribed and involved extremities except one. Histologic transition between benign and malignant lesion was present in only one of the 7 patients that recurred after three months of surgery for which she had to be operated again. 2 of our 7 cases were lost in follow up. Conclusion: Primary giant cell tumour of soft tissues usually present as a painless mass and needs to be differentiated from other giant cell rich soft tissue tumors. Benign clinical course is expected if the lesion is excised adequately. Its biological behaviour to have low malignant potential is recognized; but this cannot be predicted and metastasis does occur rarely.
Article
A cytohistopathological study of a rare case of giant cell tumour of soft tissues in a 30-year-old male patient is presented. The cytological features when evaluated in conjunction with clinical and radiological features are sufficiently diagnostic. The primary knowledge of its existence and knowledge of its cytological features are important for a correct preoperative cytologic diagnosis.
Article
We report a case of giant cell tumor of soft tissue (GCTST) in a 40-year-old woman who presented with a painful fibrous nodule on the thigh. The histological examination revealed multinucleated histiocytes admixed with eosinophils, lymphocytes, and scattered spindle-shaped cells. The clinical presentations, histological features, differential diagnosis, treatment options, and a literature review are presented.
Article
Primary giant cell tumor of soft tissue (GCTST) arising in a finger is a rare event. We report a case of a 54-year-old man with a primary finger giant cell tumor that appeared histologically identical to giant cell tumor of bone. The patient presented with a cystic mass of the finger. The magnetic resonance imaging showed no relation between the nodule and bone, tendons or synovial tissues. The distinction of this entity from other more common primary finger tumors with giant cell morphology is emphasized.
Article
The malignant giant cell tumor of soft parts is an extraskeletal malignant neoplasm somewhat resembling a giant cell tumor of bone and consisting of multinucleated giant cells (occasionally containing asteroid bodies), monon-nuclear histiocytes, and fibroblasts arranged in a multinodular pattern. Thirty-two cases of this tumor in the AFIP files were reviewed and subdivided into a superficial and a deep group; the superficial tumors (12 cases) were small and occurred in the region of the subcutis and superficial fascia, with a predilection for the leg. They recurred frequently after excision, but only two metastasized and terminated in death. Six of the 12 patients with superficial tumors survived 5 or more years following local excision. The deep tumors were large and involved skeletal muscle, deep fascia, and tendons. They affected the thigh chiefly. Fourteen of the 20 patients developed pulmonary or widespread metastasis and died; eight of the 14 had been treated by amputation of the extremity. Four of the 20 patients with deeply located malignant giant cell tumor of soft parts survived 5 years.
Article
Twenty-two cases of giant cell tumor of soft tissues (GCT-ST) identified in the Mayo Clinic files and the consultation files of two of the authors (A.G.N., C.D.M.F.) were analyzed clinicopathologically. Age at presentation ranged from 5 to 80 years (median, 43 years), and there was no sex predilection (12 male, 10 female). Duration of symptoms ranged from 2 to 12 months (median, 4.5 months), and a painless growing mass was the most common complaint. The lower limbs were the most frequent location (50%), followed by the trunk (31.8%) and the upper limbs (13.6%). The size of the tumors ranged from 1 to 10 cm, and they tended to be superficial (86.4%), forming well-circumscribed (72.7%), multinodular (86.4%) masses. Histologically, all tumors consisted of a mixture of mononuclear cells showing vesicular, round to oval nuclei and osteoclastlike, multinucleated giant cells distributed uniformly throughout the tumors. Foci of stromal hemorrhage were observed in 11 tumors (50%); nine tumors (40.1%) showed metaplastic bone formation and six (27.2%) showed aneurysmal bone cystlike areas. Necrosis was absent in all but one tumor. Mitotic figures were present in all but one tumor, ranging from two to more than 30 mitoses per 10 high-power fields (HPFs; median, 9.5 mitoses per 10 HPFs) and were typical in aspect. Vascular invasion was identified in seven tumors (31.8%), and none of the tumors showed marked cellular atypia or pleomorphism. The tumors were treated surgically, and follow-up information was available for 16 patients (duration of follow-up, 2 to 130 months; median, 51 months). Only one of the 16 patients (6.2%) had local recurrence and lung metastases; this patient died of the tumor. In conclusion, GCT-ST occurs as a primary soft-tissue neoplasm and is identical clinically and morphologically to giant cell tumor of bone. Provided that GCT-ST is treated adequately by complete excision, a benign clinical course is expected because episodes of distant metastasis and tumor-associated death seem to be exceedingly rare.
Article
Primary giant cell tumors (GCTs) of soft tissue resembling osseous GCTs are uncommon but distinct entities. Malignant GCTs of soft tissue have been designated giant cell malignant fibrous histiocytomas; however, there is scant data regarding benign GCTs of soft tissue. Eleven benign and seven malignant GCTs of soft tissue were identified from the authors' consultation files and the surgical pathology files of the Vancouver General Hospital and Massachusetts General Hospital. The tumors occurred in adults (eight men, 10 women; age range, 25-89 years; mean age, 54 years) in the extremities (n = 14) and in the trunk, abdomen, and pelvis (n = 4). In each patient the skeleton was normal and there was no history of prior osseous GCT. Tumors ranged in size from 0.8 to 9.0 cm. Eleven occurred in the superficial soft tissue and seven occurred in deep soft tissue. Grossly they were circumscribed and frequently hemorrhagic. Cystic change was present in seven tumors. Nine tumors were partially surrounded by a shell of reactive bone. In all tumors, multinucleated osteoclast-like giant cells were distributed uniformly and evenly among mononuclear cells. The histologically benign GCTs of soft tissue were identical to typical osseous GCTs. The mononuclear cells in these tumors lacked nuclear atypia or pleomorphism, and the mitotic rate within this population was low (mean, three mitoses per 10 high-power fields [HPF]). In the malignant GCTs of soft tissue, the mononuclear cells exhibited anisocytosis, nuclear atypia, pleomorphism, and readily detectable mitoses including atypical forms (mean, 25 mitoses per 10 HPF). None of the benign or malignant tumors exhibited neoplastic bone production. The benign and malignant GCTs of soft tissue demonstrated a similar immunohistochemical staining profile to GCT of bone ( 12 tumors examined), exhibiting strong positive staining for CD68 within multinucleated osteoclastlike cells, and focal staining of mononuclear cells for CD68, Ham 56, and smooth muscle actin. All tumors were treated by surgical resection. Follow-up information is available for 15 patients (range, 0-108 months). No benign tumor has recurred or metastasized. Of the four patients with malignant tumors for whom follow-up information is available, one died of metastatic disease at 13 months and one developed a local recurrence at 84 months but is alive, apparently free of disease after additional excisional surgery. Primary GCTs of soft tissue are distinctive neoplasms that, like osseous GCTs, exhibit a wide clinicopathologic spectrum. These neoplasms should be distinguished from other giant cell-rich soft-tissue tumors with which they may be confused.
Article
Primary giant cell tumor of soft tissue (GCT-ST) arising in breast is exceedingly rare. We report a case of a 60-year-old woman with a primary breast giant cell tumor that appeared histologically identical to giant cell tumor of bone and had a clinically malignant course. The patient presented with a cystic mass of the breast, suspected on imaging to be an organizing hematoma, possibly related to previous injury. Histopathological evaluation revealed a neoplasm composed of mononuclear cells admixed with osteoclast-like giant cells resembling giant cell tumor of bone. Immunohistochemical staining was positive for CD68, smooth muscle actin, and vimentin, but was negative for a panel of epithelial and additional muscle markers. These features were most consistent with GCT-ST, an uncommon neoplasm of low malignant potential. Despite aggressive surgical treatment achieving clear surgical margins, the patient expired with pulmonary metastases within a year of her initial presentation. This case demonstrates the difficulty of predicting clinical behavior of GCT-ST of breast on the basis of histological features and depth of tumor alone. To our knowledge, this is the first case report of a GCT-ST arising in the breast associated with a fatal outcome. The distinction of this entity from other more common primary breast tumors with giant cell morphology is also emphasized.